Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Nutex Health (NUTX) Asset Writedowns and Impairment (2024)

Nutex Health (NUTX) has disclosed Asset Writedowns and Impairment for 1 consecutive years, with -$11640.0 as the latest value for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$11640.0; the TTM value through Dec 2025 reached -$11640.0, changed N/A, while the annual FY2024 figure was $3.9 million, 86.63% down from the prior year.
Asset Writedowns and Impairment hit -$11640.0 in Q4 2024 for Nutex Health, down from $425000.0 in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $1.4 million in Q2 2024 and bottomed at -$11640.0 in Q4 2024.